Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,380,336 papers from all fields of science
Search
Sign In
Create Free Account
Sodium-Glucose Transporter 2
Known as:
SGLT2 Protein
, SLC5A2 Protein
, Sodium-Glucose Transporter 2 [Chemical/Ingredient]
Expand
A sodium-glucose transporter that is expressed in the luminal membrane of the PROXIMAL KIDNEY TUBULES.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
In Blood
Process of secretion
SLC5A2 gene
agonists
Expand
Narrower (1)
SLC5A2 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
An Investigation on Molecular Basis of the Effects of SGLT2 İnhibitor Dapagliflozin on Hyperglycemia-Associated Heart Dysfunction*
Aysegul Durak
,
Y. Olgar
,
+9 authors
B. Turan
Journal of Ankara University Faculty of Medicine
2018
Corpus ID: 58139121
Geliş Tarihi/Received: 05.07.2018 Kabul Tarihi/Accepted: 05.11.2018 Amaç: Sodyum glukoz ko-transporter (SGLT) inhibitörlerinin…
Expand
2018
2018
Ингибиторы SGLT2: взгляд на кардиобезопасность
Моргунов Леонид Юльевич
2018
Corpus ID: 200208813
Review
2017
Review
2017
Design and Solubility Enhancement of Empagliflozin Immediate Release Tablets by Using Solid Dispersion Method
S. Martha
,
N. Potnuri
2017
Corpus ID: 212578871
To review available studies of Empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014 by the…
Expand
2016
2016
SGLT2-unabhängige metabolische Wirkungen von Dapagliflozin bei Patienten mit Typ-2-Diabetes
S. Kahl
Der Diabetologe
2016
Corpus ID: 41110267
Hintergrund. Der SGLT2-Inhibitor Dapagliflozin verringert die Plasmaglukosekonzentration durch Hemmung des renalen Natrium…
Expand
2015
2015
SGLT2 阻害薬：基礎と臨床
池田富貴
,
ほか
2015
Corpus ID: 179366258
ナトリウム/グルコース共輸送担体（SGLT…
Expand
2015
2015
SGLT2 阻害薬に違いはあるか？―薬物動態における特徴の比較―
成寿 西山
,
ほか
2015
Corpus ID: 179107103
2014
2014
Sodium glucose transporter 2 (sglt2) inhibitors: Current status in clinical practice.
D. Dutta
,
S. Kalra
JPMA. The Journal of the Pakistan Medical…
2014
Corpus ID: 13519499
Sodium glucose transporter 2 (SGLT2) inhibitors including dapagliflozin, canagliflozin and empagliflozin act by a novel insulin…
Expand
2014
2014
SGLT2 Inhibitors: Mechanism of Action, Pros, and Cons
2014
Corpus ID: 145899185
Sodium glucose cotransporter 2 inhibitors act independently of insulin level and so can be used at various stages of type 2…
Expand
2013
2013
Weight control: key to managing ‘diabesity’:
D. Haslam
2013
Corpus ID: 73275278
A link between obesity and type 2 diabetes has been noted for millennia, and particularly in more recent centuries, with the…
Expand
2010
2010
Ｓｇｌｔ２ 억제제, ｄｐｐ－ｉｖ 억제제 및 임의로 추가의 당뇨병 치료제를 포함하는 약제학적 조성물 및 이의 용도
페터 아익켈만
,
미카엘 마르크
,
세만 레오존
,
레오 토마스
,
울리 브뢰들
,
롤프 그렘플러
2010
Corpus ID: 188426433
본 발명은 1형 당뇨병, 2형 당뇨병, 내당능 장애 및 고혈당증으로부터 선택된 하나 이상의 상태를 치료 또는 예방하는 데 적합한, SGLT2 억제제, DPP IV 억제제 및 제3 당뇨병 치료제를 포함하는 제1…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE